Eske M Derks

researcher

Born 1975-07-11

Eske M Derks is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-6292-6883
P1053ResearcherIDA-1652-2017
P1153Scopus author ID6602753396

P108employerQIMR Berghofer Medical Research InstituteQ7270958
P734family nameDerksQ37020001
DerksQ37020001
DerksQ37020001
P735given nameEskeQ18073654
EskeQ18073654
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q41119525"Forward genetics" as a method to maximize power and cost-efficiency in studies of human complex traits
Q43742579A genome wide survey supports the involvement of large copy number variants in schizophrenia with and without intellectual disability.
Q38558394A guide on gene prioritization in studies of psychiatric disorders.
Q42639489A study of genetic and environmental influences on maternal and paternal CBCL syndrome scores in a large sample of 3-year-old Dutch twins
Q45260924A systems medicine research approach for studying alcohol addiction
Q42689121A test of the equal environment assumption (EEA) in multivariate twin studies
Q52372349A tutorial on conducting genome-wide association studies: Quality control and statistical analysis.
Q39408279A two-factor structure of first rank symptoms in patients with a psychotic disorder
Q51897435Across the continuum of attention skills: a twin study of the SWAN ADHD rating scale.
Q55128222Analysis of shared heritability in common disorders of the brain
Q58896809Antipsychotic Drug Treatment in First-Episode Psychosis
Q35880978Assessment and etiology of attention deficit hyperactivity disorder and oppositional defiant disorder in boys and girls
Q57515292Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank
Q34918790Assumptions and properties of limiting pathway models for analysis of epistasis in complex traits
Q40255436Attention problems and attention-deficit/hyperactivity disorder in discordant and concordant monozygotic twins: evidence of environmental mediators
Q92548462Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability
Q37021274Body integrity identity disorder crosses culture: case reports in the Japanese and Chinese literature
Q45728809Categorical and dimensional psychopathology in Dutch and US offspring of parents with bipolar disorder: A preliminary cross-national comparison.
Q45746100Cognitive biases and auditory verbal hallucinations in healthy and clinical individuals.
Q47134438Cohort profile: the Healthy Life in an Urban Setting (HELIUS) study in Amsterdam, The Netherlands
Q43990949Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
Q34445382Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study
Q59784164Correction: Investigation of the Genetic Association between Quantitative Measures of Psychosis and Schizophrenia: A Polygenic Risk Score Analysis
Q34807118Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.
Q38807396Dietary pattern derived by reduced rank regression and depressive symptoms in a multi-ethnic population: the HELIUS study.
Q30938787Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST).
Q37504778Does assessment type matter? A measurement invariance analysis of online and paper and pencil assessment of the Community Assessment of Psychic Experiences (CAPE).
Q43142810Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).
Q48569317Effects of censoring on parameter estimates and power in genetic modeling
Q38486684Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Q47767440Emotion processing in schizophrenia is state and trait dependent
Q38683389Ethnic differences in current smoking and former smoking in the Netherlands and the contribution of socioeconomic factors: a cross-sectional analysis of the HELIUS study
Q40114019Evidence of selection on splicing-associated loci in human populations and relevance to disease loci mapping
Q34192331Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses.
Q57333490Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use
Q36121493Focal and global brain measurements in siblings of patients with schizophrenia
Q57700145GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
Q38378189Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST).
Q59784166Genetic Analyses of Maternal and Teacher Ratings on Attention Problems in 7-year-old Dutch Twins
Q36428470Genetic and environmental influences on the relation between attention problems and attention deficit hyperactivity disorder
Q115044824Genetic correlates of socio-economic status influence the pattern of shared heritability across mental health traits
Q38255331Genetic liability for schizophrenia predicts risk of immune disorders
Q36612177Genetic schizophrenia risk variants jointly modulate total brain and white matter volume
Q52560096Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Q57700827Genome-wide association meta-analysis of age at first cannabis use
Q28274406Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium
Q34322551Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.
Q39186435How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses
Q35369895Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia
Q46348167Individual differences in aggression: genetic analyses by age, gender, and informant in 3-, 7-, and 10-year-old Dutch twins
Q50536511Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial.
Q45938032Interpreting treatment trials in schizophrenia patients: lessons learned from EUFEST.
Q28728068Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis
Q35898724Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls
Q54478192Letter to the Editor: Schizophrenia does not represent the extreme of a normally distributed trait.
Q42686912Longitudinal stability of the CBCL-juvenile bipolar disorder phenotype: A study in Dutch twins
Q37435358Maternal ratings of attention problems in ADHD: evidence for the existence of a continuum
Q58744398Measurement invariance of the SF-12 among different demographic groups: The HELIUS study
Q42634186Measurement invariance testing of the PHQ-9 in a multi-ethnic population in Europe: the HELIUS study
Q92001122Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits
Q39445777Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach
Q30882470Netherlands Twin Register: a focus on longitudinal research
Q37384507Neuroimaging of response interference in twins concordant or discordant for inattention and hyperactivity symptoms
Q50303685No evidence that common genetic risk variation is shared between schizophrenia and autism
Q59784159Parental Smoking and Adult Offspring’s Smoking Behaviors in Ethnic Minority Groups: An Intergenerational Analysis in the HELIUS Study
Q21090200Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture
Q38783816Perceived ethnic discrimination in relation to smoking and alcohol consumption in ethnic minority groups in The Netherlands: the HELIUS study
Q62705166Potential influence of socioeconomic status on genetic correlations between alcohol consumption measures and mental health
Q39963096Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
Q42671420Prevalence and genetic architecture of Child Behavior Checklist-juvenile bipolar disorder
Q48463587Qualitative and quantitative aspects of information processing in first psychosis: latent class analyses in patients, at-risk subjects, and controls
Q59784162Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls
Q44584237Replication and refinement of the role of rs548181 in schizophrenia: results from a family based study
Q34313985Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples
Q47598957Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence
Q62705199Sex differences in the genetic architecture of obsessive-compulsive disorder
Q57269642Sex differences in the genetic architecture of obsessive-compulsive disorder
Q48470067Social cognition and quality of life in schizophrenia
Q33286295Statistical power to detect genetic and environmental influences in the presence of data missing at random
Q49826381The Biological Contributions to Gender Identity and Gender Diversity: Bringing Data to the Table
Q33600077The Relation Between Inflation in Type-I and Type-II Error Rate and Population Divergence in Genome-Wide Association Analysis of Multi-Ethnic Populations
Q35018781The association between intelligence scores and family history of psychiatric disorder in schizophrenia patients, their siblings and healthy controls
Q59784165The calculation of familial loading in schizophrenia
Q51926379The genetic and environmental contributions to attention deficit hyperactivity disorder as measured by the Conners' Rating Scales--Revised.
Q42665422The genetic and environmental contributions to oppositional defiant behavior: a multi-informant twin study
Q34324778The identification of family subtype based on the assessment of subclinical levels of psychosis in relatives
Q39188766The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials
Q44612421The influence of informant characteristics on the reliability of family history interviews
Q38469134The influence of semantic top-down processing in auditory verbal hallucinations
Q48537147The interrelation of needs and quality of life in first-episode schizophrenia
Q51913880The latent class structure of ADHD is stable across informants.
Q48256587The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state?
Q59784163The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder
Q53693542The relation between obesity and depressed mood in a multi-ethnic population. The HELIUS study.
Q51921126The relations between DISC-IV DSM diagnoses of ADHD and multi-informant CBCL-AP syndrome scores.
Q33506106The relationship of DNA methylation with age, gender and genotype in twins and healthy controls
Q46620463The relative contribution of genes and environment to alcohol use in early adolescents: are similar factors related to initiation of alcohol use and frequency of drinking?
Q27025380The treatment of hallucinations in schizophrenia spectrum disorders
Q34091168Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes
Q59784157Use of the Fagerström test to assess differences in the degree of nicotine dependence in smokers from five ethnic groups: The HELIUS study
Q59784158Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation
Q59784160Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder
Q62705160Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder
Q45780396Using multidimensional modeling to combine self-report symptoms with clinical judgment of schizotypy.
Q38374378What Cure Models Can Teach us About Genome-Wide Survival Analysis
Q51735117Why more boys than girls with ADHD receive treatment: a study of Dutch twins.
Q51903002Young Netherlands Twin Register (Y-NTR): a longitudinal multiple informant study of problem behavior.

Search more.